CTOs on the Move

University of Maryland Medical System

www.umms.org

 
The University of Maryland Medical System (UMMS) is a university-based regional health care system focused on serving the health care needs of Maryland. We bring innovation, discovery and research to the care we provide all while educating the state`s future physicians and health care professionals through our partnership with the University of Maryland School of Medicine and the UM Schools of Nursing, Pharmacy, Social Work and Dentistry in Baltimore. As one of the largest private employers in the state, the health system`s 25,000 employees and 4,000 affiliated physicians provide primary and specialty care in more than 150 locations and at 13 hospitals. UMMS` ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.umms.org
  • 250 W. Pratt Street
    Baltimore, MD USA 21201
  • Phone: 410.328.2450

Executives

Name Title Contact Details

Similar Companies

South End Community Health Center

South End Community Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Boston, MA. To find more information about South End Community Health Center, please visit www.sechc.org

Clinical Trials of Texas

Clinical Trials of Texas is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ga Assoc For Primary Health Care

Ga Assoc For Primary Health Care is a Decatur, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Care Products Inc

Care Products Inc is a Waterbury, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fruit Street

Fruit Street delivers the CDC`s Diabetes Prevention Program using telehealth, wearable devices, and mobile applications. The diabetes prevention program is a 1-year long diet and lifestyle intervention designed to help pre-diabetic patients lose 5-7% of their weight through diet and lifestyle changes. The program is based on clinical research that was published in the New England Journal of Medicine in 2002 which showed that patients who complete the program have a 58% risk reduction for developing diabetes.